Targeting of adenoviral vectors through a bispecific single-chain antibody

Cancer Gene Therapy

Volumn 7, Issue 6, 2000, Pages 901-904

  Haisma, Hidde J ^a   Grill, Jacques ^a,b   Curiel, David T ^a,c   Hoogeland, Susan ^a   Van Beusechem, Victor W ^a   Pinedo, Herbert M ^a   Gerritsen, Winald R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UAB Gene Therapy Center   (United States)

Author keywords

Adenoviral vectors; Antibody; Epidermal growth factor receptor; Single chain Fv

Indexed keywords

ANTIBODY CONJUGATE; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR INTRINSIC ACTIVITY;

ADENOVIRIDAE; ANIMALIA;

EID: 0033946856     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700198     Document Type: Article

References (13)

1. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320-1323.
2. 5 integrin. J Virol. 1999;73:6759-6768.
3. 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
4. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol. 1996;14: 1574-1578.
5. Rogers BE, Douglas JT, Ahlem C, Buchsbaum DJ, Frincke J, Curiel DT. Use of a novel cross-linking method to modify adenovirus tropism. Gene Ther. 1997;4:1387-1392.
6. Miller CR, Buchsbaum DJ, Reynolds PN, et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res. 1998;58: 5738-5748.
7. Haisma HJ, Pinedo HM, van Rijswijk A, et al. Tumor-specific gene transfer via an adenoviral vector targeted to the pancarcinoma antigen EpCAM. Gene Ther. 1999;6: 1469-1474.
8. Watkins SJ, Mesyanzhinov VV, Kurochkina LP, Hawkins RE. The "adenobody" approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Ther. 1997; 4:1004-1012.
9. Takahashi H, Herlyn D, Atkinson B, et al. Radioimmuno-detection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. Cancer Res. 1987;47:3847-3850.
10. Mack M, Riethmuller G, Kufer P. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc Natl Acad Sci USA. 1995;92:7021-7025.
11. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA. 1993;90:2812-2816.
12. Smith CD, Craft DW, Shiromoto RS, Yan PO. Alternative cell line for virus isolation. J Clin Microbiol. 1986;24:265-268.
13. Chan S, Gabra H, Hill F, Evan G, Sikora K. A novel tumour marker related to the c-myc oncogene product. Mol Cell Probes. 1987;1:73-82.